ArticleMolecular carcinogenesis2022

Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancer.

Shanyi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.